Pharma marketing agility: Payer current state and challenges
![](https://www.noomagroup.com/wp-content/uploads/2024/02/Pharma-marketing-agility-1024x532.png)
Marketers need to be able to navigate complex payer environments, especially as healthcare systems globally pivot towards a value-based care model. Payers now want a holistic view of a drug’s impact, extending beyond clinical efficacy to include detailed health economic and outcomes research (HEOR) and clear demonstrations of cost-effectiveness. This calls for a new breed […]